Levofloksatsin-Vista, the solution for infusions intended for treatment of such infectious diseases at adults:

• community-acquired pneumonia;
• complicated infections of leather and soft tissues;
• sharp pyelonephritis and the complicated infections of urinary tract;
• chronic bacterial prostatitis;
• inhalation anthrax: post-contact prevention and radical treatment.

Should consider official recommendations about appropriate use of antibacterial agents.

Structure

Active ingredient: levofloxacin.

1 ml of a levofloksatsin of the gemigidrat it is equivalent a levofloksatsina of 5 mg.

Excipients: sodium chloride, hydrochloric acid, sodium hydroxide, water for injections.

Contraindication

• Hypersensitivity to a levofloksatsin, other hinolon, in medicine components.
• Side reactions from sinews after preliminary application of hinolon.
• Epilepsy.
• Age up to 18 years.
• Pregnancy and period of feeding by a breast.

Route of administration

should enter Medicine slowly intravenously 1-2 times a day by drop infusion. Duration of introduction of 1 bottle of a levofloksatsin (100 ml of solution for intravenous administration from 500 mg of a levofloksatsin) has to be not less than 60 minutes.

Feature

Should avoid use of medicine to patients who had serious side reactions in the past at application of hinolon or ftorkhinolon. Treatment of these patients levofloksatsiny should be begun only in the absence of alternative options of treatment and after careful assessment of advantage / risk.

due to the lack of researches and injury of an articulate cartilage by hinolona to an organism which grows is possible

, medicine is contraindicated during pregnancy and feeding by a breast. If at use of medicine there occurred pregnancy, it is necessary to report about it to the doctor.

Children

not to use

to patients up to 18 years.

Drivers

Some side reactions (for example, dizziness / vertigo, drowsiness, a disorder of vision) can break ability of the patient to concentration of attention and speed of its reaction and, thus, to cause the increased risk in those situations when these qualities are of especially great importance (for example, at control of motor transport or other mechanisms).

Overdose

Symptoms: dizziness, violation / confusion of consciousness, convulsive attacks, tremor, lengthening of an interval of QT.

Treatment. In case of overdose it is necessary to make careful observation of the patient, including the ECG. Symptomatic treatment. The hemodialysis, including peritoneal dialysis and NAPD, is not effective for removal of a levofloksatsin from an organism. Specific antidotes do not exist.

Side effects

• from organs of sight - the disorder of vision, such as the obscured sight is rare; frequency is unknown - temporary loss of sight, a uveitis.
• from organs of hearing and a vestibular mechanism: infrequently - vertigo; seldom - sonitus frequency is unknown - a hearing disorder, a hearing loss.
• from the respiratory system, bodies of a thorax and mediastinum: infrequently - short wind frequency is unknown - a bronchospasm, an allergic pneumonitis.
• from digestive tract: often - diarrhea, vomiting, nausea infrequently - an abdominal pain, dyspepsia, a meteorism, a lock frequency is unknown - diarrhea hemorrhagic that can testify about a coloenteritis, including pseudomembranous colitis pancreatitis.
• from a liver and biliary tract: often - increase in activity of liver enzymes (ALT / nuclear heating plant, SF, GGTP) infrequently - increase in bilirubin in blood the frequency is unknown - jaundice and severe damages of a liver, including cases of development of an acute liver failure, mainly at patients with serious basic diseases, hepatitis.
• from kidneys and an urinary system: infrequently - the raised creatinine indicators in blood serum; frequency is unknown - a sharp renal failure (for example, owing to interstitial nephrite).
• from a metabolism, metabolism: infrequently - anorexia; seldom - a hypoglycemia, especially at patients with diabetes; frequency is unknown - a hypoglycemia, a hypoglycemic coma. The increased appetite, nervousness, the increased sweating, trembling of extremities can be signs of a hypoglycemia.
• from an endocrine system: seldom - a syndrome of violation of secretion of ADG (SPADG).

Interaction

any clinically significant influence on pharmacokinetics of a levofloksatsin at its application with such medicines: calcium carbonate, digoxin, glibenclamide, ranitidine.

does not recommend application of a levofloksatsin along with alcohol.

Storage conditions

For medicine does not need special storage conditions. To store out of children's reach.

Expiration date: 2 years.